Schedule 13D ownership disclosure

THERAPIX BIOSCIENCES LTD

Security class unavailable · CUSIP: 88339A203

Event date: 2020-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.2800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-014454
Form type
SC 13D/A
Filer
L.I.A. Pure Capital Ltd
CIK
CIK 1749628
Filed
Jun 09, 2020
Reporting period
Jun 04, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub